Extended antiviral therapy may not improve long COVID - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Extended antiviral therapy may not improve long COVID

Nirmatrelvir–ritonavir for up to 25 days failed to improve cognitive, autonomic, or exercise symptoms compared with placebo in a phase 2 trial.

  • By

  • Andrea Surnit

  • September 4, 2026

  • 4 min

Share

Original Source(s)

Extended antiviral therapy may not improve long COVID

  • by Andrea Surnit

  • September 4, 2026

Related Content

Microstructural alterations in brain tissue of ME/CFS and long COVID using diffusion tensor imaging and diffusion kurtosis imaging

Conformational bias in SARS-CoV-2 Spike CD4+ T-cell epitope dominance

Dynamics of neutralizing antibodies against enterovirus D68 in adults during the COVID-19 pandemic